ABSTRACT OBJECTIVES This study sought to summarize the evidence on stress myocardial perfusion imaging (MPI) using cadmium-zinc-telluride (CZT) technology for the diagnosis of obstructive coronary artery disease (CAD). The CZT cameras are newly introduced, and comparative data with the conventional Anger technology (Anger-MPI) are lacking.
R adionuclide myocardial perfusion imaging (MPI) is one of the most common stress imaging procedures performed and is a central tool in the diagnosis and assessment of risk in patients with stable ischemic heart disease (1) . Stress MPI provides important information on ischemia, scar, and left ventricular volumes and ejection fraction (2) . Anger camera technology has been the workhorse of stress MPI for decades. More recently, cadmium-zinc-telluride (CZT) cameras were introduced into clinical practice by 2 vendors (3) (4) (5) (6) (7) (8) (9) (10) . This technology is now available for clinical application with anecdotal reports on suboptimal image quality due to patient motion, incorrect positioning, or obesity, which potentially may lead to reduced specificity (11) (12) (13) .
The primary aim of this report was to evaluate the current evidence on the diagnostic accuracy of CZT-MPI. Thus, we conducted a systematic review and meta-analysis of the available published literature (14) (15) (16) .
METHODS
STUDY DESIGN. This review was prepared in keeping with The Cochrane Collaboration recommendations (14, 17) and the current Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Online Table 1S ) (18). with an univariate model (14, 20, 21) .
Our primary analysis used Reitsma bivariate and proportional hazard models, which are less prone to bias given the correlation between sensitivity and false-positive rate (1 À specificity) that is typical of diagnostic studies (14, 20, 21) . The presence of a threshold effect with potentially biasing effects was analyzed with the Spearman correlation test (14) .
We also used meta-regression utilizing a Reitsma bivariate model for sensitivity and false-positive rate, Study quality overall was high despite the pragmatic features of most studies, which were typically characterized by a potential selection bias for coronary angiography (Online Table 2S ). The studies were published between 2010 and 2016, and were mostly singlecenter retrospective observational reports ( Table 1) .
Median age of patients was 63 years. Most series included men and overweight-obese patients, with the obese patients being the sole focus of enrollment in 2 studies. Moreover, diabetics accounted for a sizeable proportion of enrolled patients (average 34% of subjects), and nearly one-half of the patients had prior coronary artery disease (CAD) ( Table 1 , Online Table 3S ). The majority of reported patients had stable CAD (either suspected or known), except for patients included in the study by Duvall et al. (30) , who were evaluated for acute chest pain. A stress/rest protocol was used in all studies, and dual isotope administration was used in 2 (Online Table 4S ). The Discovery NM 530c or Discovery NM/CT 570c camera (with Alcyone technology, GE Healthcare, Haifa, Israel) was used in 12 studies, whereas the D-SPECT (Spectrum Dynamics, Palo Alto, California) was used in the remaining Positive MPI was defined based on stress-only MPI in 9 studies and using stress and rest MPI in 7 studies.
Significant CAD was defined using qualitative coro- Heterogeneity was appraised using the chi-square test, with corresponding degrees of freedom (df) and p value. CI ¼ confidence interval. Finally, image quality was inconsistently reported and thus could not be appraised in detail.
CONCLUSIONS
MPI with the novel CZT technology has relatively comparable diagnostic sensitivity for angiographically-significant CAD to Anger-SPECT.
The reduced diagnostic specificity, which resulted in a high rate of false-positive findings with CZT-MPI, warrants further research, particularly as it relates to imaging of obese patients. 
